11 Stocks with Consistent Growth to Buy Now

5. Lantheus Holdings, Inc. (NASDAQ:LNTH)

5-Year Average Growth Rate: 129.65%

No. of Hedge Funds: 39

Based in Massachusetts, Lantheus Holdings, Inc. (NASDAQ:LNTH) is a medical imaging company developing diagnostic and therapeutic radiopharmaceuticals. Their flagship product, Pylarify®, is a PET imaging agent for prostate cancer. Focusing on nuclear medicine innovation and targeted diagnostics, the company gains a competitive edge against players like GE HealthCare and Bracco Diagnostics. The company’s strong pipeline supports leadership in precision oncology, allowing the company to benefit from increasing demand for non-invasive, high-accuracy cancer diagnostics in clinical practice.

The exceptional 129.65% growth average from the past five years distinguishes Lantheus Holdings, Inc. (NASDAQ:LNTH) as a diagnostic imaging and radiopharmaceuticals leader. With a fourth-quarter revenue of $391.1 million, the company achieved an increase of 10.5% year over year in 2024. The biggest contributor was PYLARIFY, which had $1 billion in sales in 2024. Their outlook also looks promising, with an expectation to drive double-digit revenue growth starting in 2026 by enhancing capabilities in Alzheimer’s Diagnostics and Oncology Therapeutics with strategic transactions. CMS-issued rules enhance payment for specialized diagnostic radiopharmaceuticals, thereby accommodating long-term innovation. For 2025, the company intends to expand its free cash flow, which is $493.1 million for 2024.

With 39 hedge funds holding positions, Lantheus Holdings, Inc. (NASDAQ:LNTH) demonstrates growing institutional confidence in its innovation-driven strategy, making it a top contender for portfolios prioritizing stocks with consistent growth.